{"id":47595,"date":"2022-08-23T23:02:10","date_gmt":"2022-08-23T21:02:10","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/"},"modified":"2022-08-23T23:02:10","modified_gmt":"2022-08-23T21:02:10","slug":"anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/","title":{"rendered":"Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26"},"content":{"rendered":"
\n

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. <\/b>(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorder (the \u201cCompany\u201d or \u201cAnebulo\u201d), will host its inaugural R&D Day on Monday, September 26, 2022, from approximately 10:00 a.m. to 12:30 p.m. (ET) in Midtown, New York City.\n<\/p>\n

<\/a><\/p>\n

\nAnebulo\u2019s CEO, Simon Allen will be joined by Founder<\/a> Dr. Joseph Lawler, CSO Dr. Ken Cundy and other senior executives to discuss the company\u2019s vision, progress update on Anebulo\u2019s ongoing Phase 2 proof-of-concept study related to ANEB-001, commercialization\/partnership strategy, and target financial model. The event will include a question-and-answer session following presentations by Management.\n<\/p>\n

\nInstitutional investors and financial analysts are invited to attend and can register via email at AnebuloIR@mww.com<\/a>. For additional information, please contact Samantha Alphonso at salphonso@mww.com<\/a> or (212) 827-3746 as space is limited.\n<\/p>\n

\nAbout Anebulo Pharmaceuticals, Inc.<\/b>\n<\/p>\n

\nAnebulo Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse disorder. Its lead product candidate, ANEB-001, is currently in a Phase 2 clinical trial (www.clinicaltrials.gov\/ct2\/show\/NCT05282797<\/a>) to evaluate its utility in reversing the negative effects of acute cannabinoid intoxication within one hour of administration. This trial is being run in the Netherlands by the Centre for Human Drug Research (CHDR). ANEB-001 is a competitive antagonist at the human cannabinoid receptor type 1 (CB1). For further information about Anebulo, please visit www.anebulo.com<\/a>.\n<\/p>\n

\nForward-Looking Statements<\/b>\n<\/p>\n

\nThis press release contains forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, along with terms such as \u201canticipate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cshould\u201d and other comparable terms, involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Those statements include statements regarding the intent, belief or current expectations of Anebulo and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including risks attendant to developing, testing and commercializing the company\u2019s product candidates, and those described in Anebulo\u2019s most recent annual report on Form 10-K and in other periodic reports filed with the SEC, and that actual results may differ materially from those contemplated by such forward-looking statements. Except as required by federal securities law, Anebulo undertakes no obligation to update or revise forward-looking statements to reflect changed conditions.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAnebulo Pharmaceuticals, Inc.<\/b>
Scott Anderson
\n
Head of Investor Relations and Public Relations
\n
(858) 229-7063
\n
scott@anebulo.com<\/a>\n<\/p>\n

\nRex Merchant
\n
Chief Financial Officer
\n
(512) 598-0931
\n
IR@anebulo.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorder (the \u201cCompany\u201d or \u201cAnebulo\u201d), will host its inaugural R&D Day on Monday, September 26, 2022, from approximately 10:00 a.m. to 12:30 p.m. (ET) in Midtown, New York City. Anebulo\u2019s … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47595","6":"format-standard","7":"category-industry"},"yoast_head":"\nAnebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorder (the \u201cCompany\u201d or \u201cAnebulo\u201d), will host its inaugural R&D Day on Monday, September 26, 2022, from approximately 10:00 a.m. to 12:30 p.m. (ET) in Midtown, New York City. Anebulo\u2019s ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-23T21:02:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220823005835\/en\/1551874\/21\/ANEB_Logo_white.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26\",\"datePublished\":\"2022-08-23T21:02:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\\\/\"},\"wordCount\":477,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220823005835\\\/en\\\/1551874\\\/21\\\/ANEB_Logo_white.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\\\/\",\"name\":\"Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220823005835\\\/en\\\/1551874\\\/21\\\/ANEB_Logo_white.jpg\",\"datePublished\":\"2022-08-23T21:02:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220823005835\\\/en\\\/1551874\\\/21\\\/ANEB_Logo_white.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220823005835\\\/en\\\/1551874\\\/21\\\/ANEB_Logo_white.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/","og_locale":"en_US","og_type":"article","og_title":"Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26 - Pharma Trend","og_description":"AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorder (the \u201cCompany\u201d or \u201cAnebulo\u201d), will host its inaugural R&D Day on Monday, September 26, 2022, from approximately 10:00 a.m. to 12:30 p.m. (ET) in Midtown, New York City. Anebulo\u2019s ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-23T21:02:10+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220823005835\/en\/1551874\/21\/ANEB_Logo_white.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26","datePublished":"2022-08-23T21:02:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/"},"wordCount":477,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220823005835\/en\/1551874\/21\/ANEB_Logo_white.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/","url":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/","name":"Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220823005835\/en\/1551874\/21\/ANEB_Logo_white.jpg","datePublished":"2022-08-23T21:02:10+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220823005835\/en\/1551874\/21\/ANEB_Logo_white.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220823005835\/en\/1551874\/21\/ANEB_Logo_white.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/anebulo-pharmaceuticals-to-host-inaugural-rd-day-in-new-york-city-on-monday-september-26\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47595","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47595"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47595\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47595"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}